Lipella Pharmaceuticals Highlighted Clinical Data On LP-20, A Novel MRI Contrast Agent Designed For Diagnosing Interstitial Cystitis And Detecting Bladder Cancer At The 5th International Consultation On Interstitial Cystitis Japan In Kyoto, Japan
Lipella Pharmaceuticals Highlighted Clinical Data On LP-20, A Novel MRI Contrast Agent Designed For Diagnosing Interstitial Cystitis And Detecting Bladder Cancer At The 5th International Consultation On Interstitial Cystitis Japan In Kyoto, Japan
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated